Egbuonu-Davis Lisa 4

What Happened
Lisa Egbuonu‑Davis, a director of Omega Healthcare Investors, received a restricted stock grant of 3,778 shares on June 5, 2026. The award is recorded at $43.67 per share for a total value of $164,985. This transaction is a compensation grant (an award), not an open-market purchase or sale.

Key Details

• Transaction date: June 5, 2026; Form 4 filed June 9, 2026 (Accession 0001873318-26-000002).
• Award: 3,778 restricted shares at $43.67 each; total value $164,985.
• Vesting: The award vests on the date of the Company’s 2027 Annual Meeting of Shareholders (approximately one year from grant) and converts to common stock on a one-for-one basis (Footnote).
• Shares owned after transaction: Not reported on the Form 4.
• Transaction type: A = Award/Grant (director compensation), not a market buy or sale.

Context
Restricted stock awards to directors are common compensation and typically vest over time tied to continued service; they do not necessarily signal immediate insider sentiment about the stock. Upon vesting, the restricted shares will convert into common shares 1-for-1. The filing shows the grant promptly reported on a Form 4 filed a few days after the grant date.